Rifampin

Population Pharmacokinetics of Anti-infectives in Critically Ill Children

CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections

Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria

Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI

Population Pharmacokinetics of Anti-tuberculosis Drugs in Children With Tuberculosis

Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis

Novel Triple-dose Tuberculosis Retreatment Regimen

Rifabutin Versus Rifampicin for Treatment of Staphylococcal PJI Treated With DAIR

Hypertonic Saline for MAC

Rapid Research in Diagnostics Development for TB Network

Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin

Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)

Bioneer Q-RFIA Clinical Evaluation

MRSA Decolonization in Complicated Carriage

Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis

Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis

Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T)

Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis

Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)

Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy

Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment

PanACEA - STEP2C -01

Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients

A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients

Impact of Rifampicin in Treatment Outcome of Cutibacterium Acnes Prosthetic Joint Infections

A Novel Therapy With a 1-Month Ultrashort Regimen to Halt Progression From Latent Infection to Active Tuberculosis Among Close Contacts (The TB-YOUTH Study)

Pragmatic Optimized Rifampicin Trial

Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

Asymptomatic TB With Innovative Modified Short-course Regimens

Rifampicin Combination Therapy Versus Monotherapy for Staphylococcal Prosthetic Joint Infection

ATORvastatin in Pulmonary TUBerculosis

Novel Interventions and Diagnostic Tests for Leprosy

Shortened Regimen for Drug-susceptible TB in Children

Precision Rifampin Trial for Personalized Dosing

Efficacy Safety BaiDiZiYin ShenQiYiFei Adjunctive Treatments Pulmonary Tuberculosis

Ampicillin and Ceftriaxone for the Treatment of Enterococcus Faecalis Infective Endocarditis.

Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

Adjunctive Doxycycline for Central Nervous System Tuberculosis

Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment

Shorter and Safer Treatment Regimens for Latent TB

Amikacin Liposome Inhalation Suspension for Treatment of Mycobacterium Xenopi Pulmonary Infection

Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis

Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial

A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide

ROADMAP Clinical Trial

A Phase 1/2 Study to Evaluate the Safety, PK and Efficacy of TNP-2092 Administered Via IA Injection in PJI Participants

A PAN-USR TB Multi-Center Trial

Identification of New Tools for Predicting Natural Metabolic Performance of the Liver

Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of RESP30TB in Tuberculosis

Short-term Bactericidal Effect of Contezolid in MAC-PD

Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)

A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets

A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis

Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease

BPaLMZ for TB Meningitis

ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)

Rifampin-combined Antibiotic Therapy for Staphylococcal PJI

Rifampin-free Regimen Versus Rifampin-containing Regimen in the Treatment of Staphylococcal Prosthetic Valve Endocarditis

An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healthy Adult Participants

A Study Evaluating the Effects of Itraconazole or Rifampin on the Pharmacokinetic Characteristics of Rocbrutinib Tablet

Phase I Study of QLC5508 in Advanced Solid Tumors: C-QTc, Pharmacokinetics (PK) Comparisons and Drug-drug Interaction

Population Pharmacokinetic Model of Rifampicin in Staphylococcal Osteoarticular Infections

A Study of Navlimetostat (BMS-986504) Drug Interactions and Food Effect in Healthy Participants

Drug-Drug Interaction Study of Vorolanib Tablets in Healthy Participants

Drug-Drug Interaction Study of Befotertinib Capsules in Healthy Participants.

Latent Infection Freshmen Tracking for Tuberculosis

A Phase 1 Multiple Dose Trial in Healthy Adult Participants to Evaluate the Safety, Tolerability, Drug-Drug Interactions, and Pharmacokinetics of TBD11

Ablation Versus Non-ablation Strategies for Non-puerperal Mastitis: A Prospective Real-world Registry Study

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis

The Treatment of Tuberculosis in HIV-Infected Patients

Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease

TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis

TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis

Tuberculosis Prevention for HIV Infected Adults

Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults

Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis

Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)

Clinical Trial of Rifampin and Azithromycin for the Treatment of River Blindness

Treatment of Latent TB Infection for Jailed Persons

Tuberculosis Treatment Shortening Trial

TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment

TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment

Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9)

Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment

Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs

Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer

Prediction of Drug Interactions With CYP2C9 Substrates

The Utility of Levofloxacin-Rifampin in the Therapy of Prosthetic Joint Infection

Impact of Ventricular Catheter Used With Antimicrobial Agents on Patients With a Ventricular Catheter

Vancomycin vs. Vancomycin Plus Gentamycin in Treatment of MRSA Infection

Pharmacokinetic Interaction Study in Indonesian Tuberculosis Patients Indonesia

A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of Tuberculosis

BURULICO Drug Trial Study Protocol: RCT SR8/SR4+CR4, GHANA

Cotrifazid Safety and Efficacy Against Malaria

Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria

Clarithromycin v Ciprofloxacin Added to Rifampicin + Ethambutol, for Opportunist Mycobacterial Pulmonary Disease

Study of Catheter-related Infections Using Antibiotic-coated Versus Conventional Catheters in Children

Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis

Study to Determine the Impact of Multiple Doses of Rifampin on Single-dose Pharmacokinetics of HCV-796

Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection

Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis

A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy

A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant).

Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Anti-TB Drugs Induced Liver Damage

The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin

Effects of Rifampin on the Pharmacokinetics of Nilotinib in Healthy Subjects

Effect of a Potent Inducer Rifampicin on the Pharmacokinetics of Deferasirox in Healthy Volunteers

Rifampin Combination Therapy Versus Monotherapy in Early Staphylococcal Infections After Total Hip and Knee Arthroplasty

Effects of Doxycycline and Rifampicin on Biomarkers of Alzheimer's Disease in the Cerebrospinal Fluid

Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis

Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy

Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin

Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)

A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIV

Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg

A Study of the Interaction of Rifampin and Vinflunine in Subjects With Advanced Cancer

Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia

Controlled Trial: 5-day Course of Rifampin Versus Doxycycline for the Treatment of Mild to Moderate Scrub Typhus

A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC) Lung Disease

Use of Azithromycin and Rifabutin Administered 3 Times Weekly for the Treatment of M. Avium Complex (MAC) Lung Disease

An Open-Label Study to Assess the Effect of CYP3A4 Induction on the Pharmacokinetics of VELCADE (Bortezomib)

Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis

Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients

Sulforaphane as an Antagonist to Human PXR-mediated Drug-drug Interactions

Uniform Multidrug Therapy Regimen for Leprosy Patients

MRI to Measure Treatment With Antibiotics in Alzheimer's Disease

TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment

Healthy Volunteer Study of Clopidogrel and Rifampicin

Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis

Durability of Nevirapine-Based Antiretroviral Regimen

Randomized Clinical Trial to Compare a Regimen of Trimethoprim-sulfamethoxazole Plus Rifampicin With a Regimen of Linezolid in the Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection

A Pilot Study of Inflammatory Markers in Alzheimer's Disease

Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy

Effect of Rifampin on Bosutinib When Both Are Given to Healthy People

Rifapentine Plus Moxifloxacin for Treatment of Pulmonary Tuberculosis

TMC435350-TiDP16-C105: Phase I, 3-way Crossover, Drug-drug Interaction Between TMC435350 and Rifampin After Multiple Dosing.

Study of the Effect of Rifampicin on the Pharmacokinetics (PK) of Multiple Doses of Cediranib in Patients With Solid Tumours

Pharmacokinetics and Pharmacodynamics of High Versus Standard Dose Rifampicin in Patients With Pulmonary Tuberculosis

Active Screening of Latent TB Infection, Treatment and Long Term Follow-up in Prison

An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin

Pharmacokinetic Interaction Study to Assess the Effect of Repeat Doses of Rifampin on Mirabegron (YM178) in Healthy Volunteers

Drug Interaction Study of Rifampin and Warfarin in Healthy Volunteers.

Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children

Study of Daily Rifapentine for Pulmonary Tuberculosis

Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis

Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis

Prospective Study of N-acetyltransferase2 (NAT2) and Cytochrome P4502E1 (CYP2E1) Gene as Susceptible Risk Factors for Antituberculosis (ATT) Induced Hepatitis

Evaluation of the Pharmacokinetics of NRL972 Following Pre-Administration of Rifampicin and Cyclosporine

Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis

Study Evaluating The Potential Effect Of Rifampin On The Pharmacokinetics Of Neratinib

Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications

LEVOS - Levofloxacin and Rifampicin Therapy in the Treatment of OsteoArticular Prothethic Infection

CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery

Anti-tuberculosis (TB) Drug Levels and Hepatotoxicity

Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness

Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis

Interplay Between Organic Anion Transporting Polypeptide (OATP) Transporters Transporters and CYP2C9 in Glyburide Pharmacokinetics (PK)

A Study to Evaluate the Effect of Ketoconazole and Rifampicin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers

Pharmacokinetic Study for Anti-tuberculosis Drugs

Study Analyzing the Effect of Rifampicin Administration on the Pharmacokinetics of Neramexane Mesylate

Validation Study of Multiple Probe Compounds for Drug Interaction Evaluation

Pregnane X Receptor (PXR) Agonist Rifampicin Effects on Glucose, Lipid and Hormone Homeostasis

Drug-Drug Interaction Study With Rifampin

Study of VX-770 and Rifampin in Healthy Male Subjects

Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35)

CYP2C9 Activity Evaluated With a Simple Finger Prick

CATCH - Catheter Infections in Children

Trial Comparing Efficacy of Treatments for Hidradenitis Suppurativa

Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy Subjects

Trial of Antimycobacterial Therapy in Sarcoidosis

Influence of Drug-drug Interactions on the Pharmacokinetics (PK) of Voriconazole

Rifampin Drug-Drug Interaction Study With Lurasidone HCl

A Study to Assess the Effect of Rifampin on the Metabolism of Navitoclax

Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy

Daptomycin With Rifampin for Treatment of Staphylococcal Prosthetic Joint Infection

Estimation Of Effect Of Rifampin On Pharmacokinetics Of Crizotinib In Healthy Volunteers

Latency in Pulmonary Tuberculosis

Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability Study

Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy Volunteers

Investigation of the Efficacy of Antibiotics on Pulmonary Sarcoidosis

Estimate The Effect Of Repeat-Dose Rifampin On The Pharmacokinetics Of CP-690,550 In Healthy Volunteers

Identification and Evaluation of Endogenous Markers for the Assessment of CYP3A Activity Using Metabolomics

Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With(J-M-Pa-Z) (NC-001)

Early Bactericidal Activity (EBA) of SQ109 in Adult Subjects With Pulmonary TB

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid Tumors

Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients

PNU-100480 In Newly Diagnosed, Drug Sensitive Patients With Pulmonary TB; Early Bactericidal Activity; Whole Blood Assay

Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female Volunteers

Efficacy of Antituberculous Therapy in Management of Sarcoidosis

Effect Of Rifampin On Pharmacokinetics Of Sitaxsentan

MESS-study MRSA Eradication Study Skåne

A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies

Study of Rifampicin in Multiple System Atrophy

Effects of Pregnane X Receptor (PXR) Activation on Human Glucose, Lipid and Hormone Homeostasis

Colistin Plus Rifampicin in MDR P. Aeruginosa and A. Baumanii

Bioequivalence Study Comparing Rifampicin In A Fixed-Dose Combination (Rifampicin+Isoniazid, Myrin© 2) And The Reference Drug (Rifampicin, Rimactane®)

Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for Tuberculosis

Effect of Rifampin on the Pharmacokinetics of BAY73-4506

Study to Evaluate the Effect of Rifampicin, Ketoconazole, and Omeprazole on the Pharmacokinetics of Sativex

Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer

Pharmacokinetics and Safety of Moxifloxacin

Effects of Administration of Fostamatinib on Blood Concentrations of Rifampicin in Healthy Subjects.

Cholesterol Metabolites as Markers for CYP3A Induction

TMC207 +/- Rifabutin/Rifampin

Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)

A Phase 1 Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Tivozanib in Healthy Subjects

Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients

REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment

Pharmacokinetic Study to Characterize Phenotyping Metrics of the "Basel" Cocktail After CYP Induction or Inhibition

Genetic Variability in the Response to Warfarin at Baseline and During Induction of CYP2C9

Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TB

Reintroduction Regimens After Hepatitis During Anti-tuberculosis Treatment

A Study to Evaluate the Effects of Rifampin on Single-Dose Pharmacokinetics of Canagliflozin in Healthy Volunteers

Drug Interaction Study With Rifampicin and Afatinib

Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI)

A Bioequivalence Study Comparing A Fixed Dose Combination Formulation Of Myrin P Forte That Contains Rifampicin, Isoniazid, Ethambutol And Pyrazinamide Per Tablet To An Equivalent Dose Of Single Drug Reference Preparations Of Similar Combination Following Oral Administration In Healthy Adults

Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors

To Evaluate if Multiple Doses of Rifampicin Change the Blood Concentration of YM150 (Darexaban)

Trial of High-Dose Rifampin in Patients With TB

The Effect of Intermittent Rifampicin on Raltegravir

Pharmacokinetic Drug Interaction Study in Healthy Male Subjects

Timing of Surgical Intervention in Buruli Ulcer Patients Treated With Antibiotics

Randomized Controlled Trial of Standard Versus Systemic Decolonization Therapy for the Eradication of Methicillin-resistant Staphylococcus Aureus (MRSA) Colonization

Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants

Pharmacogenetics of Warfarin Induction and Inhibition

Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or Lymphoma

Anti-tuberculosis (TB) Drug Levels and Correlation With Drug Induced Hepatotoxicity

Treatment of Methicillin-sensitive Staphylococcus Aureus (MSSA)

A Prospective Observational Study of Patients With Drug Resistant Acinetobacter Baumannii Bacteremia

Phase 2a EBA Trial of AZD5847

Study in Healthy Volunteers to Investigate the Effects of Rifampin on the Pharmacokinetics of NKTR-118

A Drug-Drug Interaction Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Apremilast

Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or Rifampin

Buprenorphine Disposition and CYP3A

Colistin and Rifampicin for MDR-Acinetobacter

Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects

Essentiality of INH in TB Therapy

A Drug-Drug Interaction Study of Ketoconazole, Rifampicin and Ritonavir-Boosted Atazanavir With Single-Dose RO5093151 in Healthy Volunteers

Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)

Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV

Directly Observed Therapy Short Course-Plus Versus DOTS for Retreatment of Relapsed Pulmonary Tuberculosis in Guangzhou

Drug-interaction Trial in Healthy Subjects With Oral Administration of Empagliflozin (BI 10773), Rifampicin and Probenecid

Pharmacokinetics of Tasimelteon Alone and in Combination With a CYP3A4 Inhibitor, Ketoconazole, or a CYP3A4 Inducer, Rifampin.

A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Abiraterone in Healthy Male Participants

WHO Drug Study for Buruli Ulcer - Comparison of SR8 and CR8

Efficacy and Safety of Modified Anti-tubercular Regimens in Treatment of Tuberculosis in Patients With Underlying Compensated and Decompensated Chronic Liver Disease

A Study to Investigate the Effects of Rifampicin on the Pharmacokinetics of Aleglitazar in Healthy Volunteers

The Effect of PXR Activation on Blood Pressure Regulation

Rifampin and Nevirapine Interactions in Young Children

Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin

Rifampin and Efavirenz Interactions in Older Children

Pharmacokinetics (PK) of Antistaphylococcal Antibiotics in Infants (NICHD-2012-02-Staph Trio)

Cocktail Approach for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood Spot

Safety, Tolerance and Pharmacokinetics of Raltegravir-Containing Antiretroviral Therapy in Infants, Children Infected With HIV and TB

Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection

Efficacy and Safety Study of Antibiotic Treatment to Treat Hip Prosthetic Joint Infection

Identification and Evaluation of Endogenous Markers for the Assessment of CYP3A Activity

A Study to Assess the Effect of Rifampin on the Pharmacokinetics of PCI-32765 in Healthy Participants

A Pharmacokinetics (PK) Study to Investigate the Effect of Rifampin on PK of Vemurafenib (Zelboraf)

Comparison of an Antibiotic Impregnated PICC Catheter Versus a Regular PICC Catheter in a Tertiary Care Setting

A Phase 1 Study to Examine the Drug-Drug Interaction of Ciprofloxacin, Itraconazole, and Rifampin on the Combination of Lumacaftor With Ivacaftor in Healthy Adult Subjects

Relative Bioavailability of a Single Dose of Nintedanib Given Alone and in Combination With Multiple Doses of Rifampicin

Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment Outcomes

Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design

The Safety of Tuberculosis Treatments by Oral Inhalation

Rifampicin Explorative PK Study for Tuberculous Meningitis Comparing Oral and Intravenous Preparation

Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TB

A Drug Interaction Study of GDC-0032 Co-administered With Rifampin or Itraconazole in Healthy Volunteers

Safety, Tolerability and Pharmacokinetic (PK) of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib

Immune Activation and Drug Absorption in HIV-Infected Patients

Effects of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sublingual and Intravenous Buprenorphine

Virgin Coconut Oil Oral Supplementation for Leprosy Patients

A Study of Evacetrapib and Rifampin in Healthy Participants

A Study of Baricitinib and Rifampicin in Healthy Participants

Study to Assess the Effect of Rifampicin (CYP Inducer) on Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours

A Pilot Study for Pharmacokinetic Parameter of Colchicine in Patient Taking Rifampin

A Study of the Effect of Multiple Doses of Rifampin on the Single Dose Pharmacokinetics of RO5424802

Phase 1 Study in Healthy Subjects to Evaluate the Effect of Rifampin on the Pharmacokinetics of IPI-145

A Phase 1 Study in Patients With Relapsed or Refractory Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma

A Study To Investigate The Drug-Drug Interaction Potential Of Rifampin OnThe Investigational Agent Palbociclib (PD-0332991)

A Pharmacokinetics (PK) Study of the Effects Rabeprazole and Rifampin on Dabrafenib in Subjects With BRAF V600 Mutation Positive Tumors

Wirelessly Observed Therapy in Comparison to Directly Observed Therapy for the Treatment of Tuberculosis

A Study to Assess the Effect of Rifampin on the Metabolism of ABT-199

Silver Graft All Comers Registry

Interaction Between High Dose Rifampicine and Efavirenz in Pulmonary Tuberculosis and HIV Co-infection

Linezolid Instead of Ethambutol in Treatment of Drug-susceptible Tuberculosis

A Bioequivalence Study Comparing A Fixed Dose Combination Formulation, Rin 150 And Individual Reference Drugs In Healthy Volunteers

CYP3A4 Activity and Mineral Homeostasis

Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis

To Assess the Effect of Rifampicin on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers

A 3-Part, Open-Label, Drug-Drug Interaction Study of Concomitant Administration of E2609 With Itraconazole, Rifampin, Digoxin, or Donepezil

Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3

A 2-Part Study to Assess Potential Metabolism-Based Drug-Drug Interactions of E2006 When Coadministered With Itraconazole, Rifampin, Midazolam, or Bupropion

Influence of Rifampin Co-Administration on the Pharmacokinetic Profile of Daptomycin

Patients Response to Early Switch To Oral:Osteomyelitis Study

The Effects of Rifampin on the Pharmacokinetics of Rosuvastatin

Improving Retreatment Success (IMPRESS)

HRZE Fasted/Fed in Newly Diagnosed TB

Antibiotic Treatment Duration for Non-Surgically-Treated Diabetic Foot Osteomyelitis

A Study to Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in Men

Optimization of the TB Treatment Regimen Cascade

High-dose Rifampicin for the Treatment of Tuberculous Meningitis: a Dose-finding Study

Relative Bioavailability of Single Doses of Dabigatran Etexilate in Healthy Volunteers

The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers.

Intensifying Multi-Drug Resistant Tuberculosis Contact Tracing by Social Network Analysis

Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection

Study to Evaluate the Effect of Multiple Doses of Rifampicin on the Multiple-dose Pharmacokinetics of Linagliptin in Healthy Volunteers

A Phase 2 to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis.

Study to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLC

A Pharmacokinetic Study to Assess the Influence of P-glycoprotein Inhibition and Simultaneous CYP3A4 and P-glycoprotein Induction on E7080 Pharmacokinetics Following Single Dose Oral Administration of 24 mg E7080 to Healthy Volunteers

PK Interaction Between Rifapentine or Rifampicin and a Single Dose of TMC207 in Healthy Subjects (TMC207-CL002)

Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation

Feasibility and Accuracy of a Novel Xpert Cartridge

COPANLISIB (BAY80-6946) Drug-drug Interaction and Cardiovascular Safety Study in Advanced Solid Tumor and Non-Hodgkin's Lymphoma Patients

A Study of LY2835219 in Healthy Participants

Assessing PA-824 for Tuberculosis (the APT Trial)

Raltegravir Versus Efavirenz in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis

Drug-Drug Interaction Study in Healthy Adult Volunteers

A Phase 2 Trial to Evaluate the Efficacy and Safety of Linezolid in Tuberculosis Patients. (LIN-CL001)

Evaluate Effects of Multiple Doses of Rifampin and Clarithromycin on the Single Dose Pharmacokinetics of Deflazacort

Efficacy and Safety of Qinbudan as an Adjunct Therapy for Retreatment Pulmonary Tuberculosis

Evaluation and Validation of Metabolic Markers for the Assessment of CYP3A Activity and Prediction of DDI

The Effects of PXR Activation on Hepatic Fat Content

Research on New Regimens for Retreatment Pulmonary Tuberculosis

Shortening Treatment by Advancing Novel Drugs

Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB

Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis

Trial of Faropenem and Cefadroxil (in Combination With Amoxicillin/Clavulanic Acid and Standard TB Drugs) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity and Effects on Novel Biomarkers

IMPAACT P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants

Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Rifampicin in Healthy Volunteers

Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy Volunteers

Effects of Rifampin on the Pharmacokinetics of Ataluren

TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens

Effect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy Subjects

PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB

Understanding The Effect Of A Strong CYP3A4 Inducer On Glasdegib Pharmacokinetics

Study in Healthy Male Subjects to Evaluate the Effect of Itraconazole and Rifampicin on the PK of Fedovapagon

Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin

PK Study of Anti-TB Drugs

Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis

The Optimal Duration of Preoperative Anti-tuberculosis Treatment of Spinal Tuberculosis

A Drug-Drug Interaction Study of N91115 +/- Rifampin in Healthy Adult Subjects

Impact of Two Genetic Variants of OATP1B3 or MRP2 or Rifampin on Systemic Disposition and Biological Efficacy of CCK-8

A Drug-drug Interaction Study of ALKS 5461 in Healthy Volunteers

Epidemiology and Treatment of Small-colony Variant Staphylococcus Aureus in Cystic Fibrosis

Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia

Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis

Phenotypic Drug Probes as Predictors of Drug-drug Interactions With Tacrolimus

A Randomised Trial to Evaluate Toxicity and Efficacy of 1200mg and 1800mg Rifampicin for Pulmonary Tuberculosis

Biomarkers for Therapy Response in Drug-resistant Tuberculosis

EVRIOS : Comparative Evaluation of Low Versus High Doses of Rifampicin

Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers

A Study to Investigate the Effect of Itraconazole and Rifampin on Pharmacokinetics (PK) of Vemurafenib at Steady State

Clindamycin-rifampin Drug Interaction in the Treatment of Bone and Joint Infections

A Drug Interaction Study in Healthy Participants to Assess the Effect of Rifampin on the Pharmacokinetics of JNJ-42847922

A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis

Xen Matrix™ AB Surgical Graft in Ventral or Incisional Midline Hernias

Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus

A Cross-over Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics (PK) of GSK525762 in Healthy Female Subjects of Non Child Bearing Potential

A Study to Assess the Effects of Itraconazole and Rifampicin on the Single-Dose Pharmacokinetics of JNJ-53718678 in Healthy Adults

A Clinical Study to Investigate the Effect of Gemfibrozil or Rifampicin on Blood Concentrations of Selexipag in Healthy Subjects

Doxycycline in Human Pulmonary Tuberculosis

Probe Melting Technology for Rapid Detection of Drug Resistant Tuberculosis

Pharmacological Interaction of Rifampicin on Clindamycin in Staphylococcic Osteoarticular Infections

A Study To Evaluate The Effect Of Rifampin On Pharmacokinetics Of PF-06463922 In Healthy Volunteers

Drug-Interaction Study to Evaluate the Effect of Rifampin, a Potent CYP3A4 Inducer, on the Systemic Exposure of Pacritinib in Healthy Subjects

Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa

Study to Assess Pharmacokinetic Drug-Drug Interaction Between Avatrombopag When Co-Administered With Fluconazole, Itraconazole, or Rifampin in Healthy Subjects

Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibition and Induction on the Pharmacokinetics of CC-220 in Healthy Subjects

Using Biomarkers to Predict TB Treatment Duration

Pharmacokinetics of Efavirenz in the Presence of Rifampicin and Isoniazid

Effect of Itraconazole on the Pharmacokinetics of Apatinib

Effect of Rifampicin on the Pharmacokinetics of Apatinib

Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Healthy Han Chinese, Korean, Japanese, and Caucasian Participants and the Effects of Rifampin on the Pharmacokinetics of Intranasally Administered Esketamine

A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas

Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in Children

Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis

Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis, Living With or Without HIV

The Bioavailability of Rifampicin in (FDCs) Widely Used in South Africa to Treat Drug-susceptible (TB)

A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects

Optimizing Treatment to Improve TBM Outcomes in Children

A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics of BMS-986177 in Healthy Subjects

Drug-drug Interaction Study Between Orally Administered Rifampicin and Vilaprisan

Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and Levofloxacin

Line Probe Assay Evaluation Study

To Assess the Effect of Rifampicin on the Pharmacokinetics of Eribulin Mesylate in Participants With Advanced Solid Tumors

Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics

Drug-drug Interaction (DDI) Study to Assess ODM-201 as a Victim of CYP3A4 Inhibition or Induction

Effect of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin

Accuracy and Feasibility of Xpert Ultra

A Study to Evaluate the Effect of Itraconazole and Rifampin on the Pharmacokinetics of Talazoparib in Patients With Advanced Solid Tumors

A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 425809 in the Blood

Drug-drug Interaction (DDI) With a P-gp Inhibitor, Organic Anion Transporting Polypeptide OATP-inhibitor, Food Effect

Drug-drug Interaction Trial Between Rifampicin and BI 409306 in Healthy Volunteers

Effectiveness of Rifabutin in the Treatment of Mycobacterium Avium Complex

S. Aureus Decolonization in HPN Patients.

Early Bactericidal Activity of Rifampin + Meropenem + Amoxicillin/Clavulanate in Adults With Pulmonary TB

RIFT: Effect of Rifampicin on Plasma PK of FTC, TAF and Intracellular TFV-DP & FTC-TP

Powder Topical Rifampicin on Reducing Infections After Neural Tube Defect Surgery in Infants

A Clinical Study Investigating Rifampicin and Dolutegravir in Combination in Healthy Volunteers

Drug-drug Interaction Study Between EDP-305, Intraconazole and Rifampin in Healthy Volunteers

The Individualized M(X) Drug-resistant TB Treatment Strategy Study

Crossover Drug-Drug Interaction Study to Determine Effects of Cytochrome P450 3A on Exposure to Mifepristone and Its Metabolites

Genetic Determinants of Clindamycin/Rifampin Interaction

Efficacy, Security, Adherence, Tolerability and Cost Effectiveness of Latent TB Treatment in Patients With TB/DM2 (TBL)

RIPE vs RIPE Plus N-acetylcysteine in Patients With HIV/TB Co-infection

Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects

Phase 1 Study to Investigate Effect of Rifampin and Itraconazole on the Pharmacokinetics of BGB-3111 in Healthy Subjects

DIAgnostics for Multidrug Resistant Tuberculosis in Africa

This Study Tests the Effect of Certain Medicines on the Transport of Other Medicines in the Body of Healthy Men

Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in Participants With Renal Insufficiency in the Presence and Absence of Rifampin (MK-0000-386)

Adverse Drug Reactions to Anti-TB Drugs in the Treatment of Latent Tuberculosis Infection

Comparison Between Rifampicin and Gemifloxacin and Ciprofloxacin in Treatment of Rhinoscleroma

Phase 2a Study of PBTZ169

Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients

Study Evaluating the Effects of Food, Cytochrome P450 Inhibition and Induction on the Pharmacokinetics of CC-122

A Study to Evaluate the Effect of 2 Drugs on the Pharmacokinetics of BMS-986205 in Healthy Subjects

Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam

Tedizolid Prolonged Treatment for Prosthetic Joint Infections

The Antibiotic Rifampin to Reduce High Levels of Blood and Urine Calcium in IIH

Statin Adjunctive Therapy for TB

Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive Tuberculosis

Rifampicin vs Rifabutin in HIV/AIDS Patients Combined With Tuberculosis

A Study to Evaluate the Effects of Rifampin on Pharmacokinetics (PK) of Pevonedistat in Participants With Advanced Solid Tumors

Drug-drug Interaction Between Belumosudil, Itraconazole, Rifampicin, Rabeprazole, and Omeprazole in Healthy Volunteers

Pharmacokinetic Study of Linezolid for TB Meningitis

Pilot Clinical Trial of PRS TB Regimen I - Phase II

A Phase 2 Study to Evaluate Early Bactericidal Activity, Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of Telacebec (Q203)

An Investigational Study to Evaluate the Effect of Rifampin on the Singe Dose of Experimental Medication BMS-986224 in Healthy Participants

A Study to Investigate the Effect of Rifampicin on the PK of Multiple Doses of Balovaptin In Healthy Volunteers

A Study in Healthy Male Subjects to Investigate Whether Administration of Rifampicin Can Affect the Fate of Clazosentan in the Body of Clazosentan

Colistin-rifampin Combination and Colistin Monotherapy in Extensively Drug-resistant Acinetobacter Baumannii

Drug-drug Interaction Study of Ozanimod With Inhibitor or Inducer of CYP2C8 and/or CYP3A

Drug Interaction Study Evaluating the Effect of Rifampin on PK and Safety of PF 04965842.

Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar

Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease

A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis

Pharmacokinetics Study to Evaluate Drug-Drug Interactions and Safety of Elpida® in Co-Administration With Other Drugs

An Investigational Study of Experimental Medication BMS-986278 Given With the Antibiotic Rifampin in Healthy Participants

Clinical Evaluation of the Truenat Point-of-care Tuberculosis Diagnostic Test

A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib

Efficacy, Safety and Pharmacokinetics of DTG With RIF

Staphylococcal Acute Post-Operative PJI Treated With 'DAIR' And Impact Of Rifampin

Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects

A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Rifampin Capsules

A Study to Learn About the Drug-drug Interactions of Sisunatovir in Healthy Adult Participants

Pharmacokinetics/Pharmacodynamics (PK/PD) of Caspofungin in Intensive Care Unit (ICU) Patients. An Open Observational Study for Antifungal Treatment's Optimization

Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) Tablet

Drug-Drug Interaction Study of Vadadustat With Cyclosporine, Probenecid and Rifampin

A Study to Investigate the Effect of Rifampicin on the Uptake and Breakdown of ACT-246475 in Healthy Subjects

Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy

Community-based Tuberculosis Tracing and Preventive Therapy

Standard Versus Double Dose Dolutegravir in Patients With HIV-associated Tuberculosis

Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating More

StAT-TB (Statin Adjunctive Therapy for TB): A Phase 2b Dose-finding Study of Pravastatin in Adults With Tuberculosis

Clinical Evaluation of Adjusted Doses of Darunavir/Ritonavir With Rifampicin in HIV-infected Volunteers

Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia

Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBM

A Study to Evaluate Drug-Drug Interaction of TAK-788 With Itraconazole and Rifampin in Healthy Adult Participants

Azacytidine During Anti-tuberculosis Therapy

Safety and Efficacy of High Dose Rifampicin in Tuberculosis (TB)-HIV Co-infected Patients on Efavirenz- or Dolutegravir-based Antiretroviral Therapy

Effect of Rifampin and Efavirenz on the Pharmacokinetics of Fedratinib in Healthy Adult Subjects

2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB.

Study to Evaluate the Effect of Multiple Doses of Itraconazole and Rifampin on the Single-Dose Pharmacokinetics of Mitapivat Sulfate (AG-348) in Healthy Adult Participants

Study to Investigate the Effect of Rifampin and Itraconazole on the Action of Pamiparib in Participants With Cancer

The Drug Interaction Between Albuvirtide (ABT) and Rifampin（RIF） in Healthy Adult Subjects

A Drug-drug Interaction Trial of Rifampicin Pharmacokinetics Effect on Fluzoparib

Adjunctive Linezolid for the Treatment of Tuberculous Meningitis

Drug-Drug Interaction Between Rifampin and Fluvastatin

BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)

Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD

A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 894416 in the Blood

Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care

A Drug Interaction Study of KW-6356 and Clarithromycin or Rifampicin

DDI Study Between Dorzagliatin and Rifampicin

Proportion of Clinical Improvement & Type 1 Interferon (IFN) Score Changes in Idiopathic Uveitis Patients With Interferon Gamma Release Assay (IGRA) Positive

Multicenter, Randomized Study Evaluating the Value of Antitubercular Treatment During Recurent Anterior Uveitis (URBA)

A Study in Healthy Subjects to Assess the Pharmacokinetics of Savolitinib When Administered Alone and in Combination With Rifampicin

A Study to Evaluate the Effect of Single-Dose Intravenous Rifampin as a Prototypic Inhibitor of Organic Anion Transporting Polypeptide (OATP) 1B1 and OATP1B3 on the Single-Dose Pharmacokinetics (PK) of Oral TAK-906 in Healthy Adult Participants

Dose Escalation Study to Determine the Pharmacokinetics of Atazanavir Administered With RIfampicin to HIV Positive Adults on sEcond-line ART Regimen With Suppressed HIV-1 Viral Load

A Phase I Study to Assess the Effect of Itraconazole and Rifampicin on Pharmacokinetics Profile of BPI-7711

A Study to Assess CYP3A4 Modulator, Oral Contraceptive, and pH Modifier Drug Interactions for ABI-H2158 in Healthy Adults

Evaluation of Centralised TB Assay Solutions

Efficacy and Safety of Intravenous Treatment of Tuberculosis

Drug Interactions Between Dolutegravir and Escalating Doses of Rifampicin

A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001

Drug-drug Interaction (DDI) Study to Assess Effect of Itraconazole and Rifampicin Upon Olorofim

Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis

Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB

Artificial Inteligent for Diagnosing Drug-Resistant Tuberculosis

Tuberculosis Drug Levels in Diabetics

Study to Evaluate the Effect of Repeat-Dose Rifampin on the Pharmacokinetics (PK) of PF-06651600

A Study to Evaluate Potential Cytochrome P450 and Transporter Protein Interactions With CC-99677

Annovera™ Drug-Drug Interaction Study

Study to Evaluate the Effect of Rifampin on the Drug Levels in Blood and Safety of BMS-986235 in Healthy Participants

Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study

The Effect of Tesetaxel on the QTc Interval and the Effect of Food, Itraconazole, and Rifampin on Tesetaxel Pharmacokinetics in Patients With Advanced Solid Tumors

The Impact of Pharmacists' Interventions on the Quality of Life of HIV-TB Co-infection Outpatients in Indonesia

Implementation of an Integrated Care Strategy for Children Contacts of Patients With Tuberculosis

Evaluation of the Effects of Irrigation of the Extraction Socket With Rifamycine

A Study to Assess the Effects of Itraconazole and Rifampin on Lazertinib in Healthy Adult Participants

The Effect of Rifampicin on the Pharmacokinetics of Intracellular Tenofovir-diphosphate and Tenofovir When Coadministered With Tenofovir Alafenamide Fumarate During the Maintenance Phase of Tuberculosis Treatment in TB/HIV-1 Coinfected Participants

Evaluation of Pharmacokinetics and Safety Tolerability of Higher Doses of Rifampic

Effect of Rifampicin on the Pharmacokinetics of SHR6390 in Healthy Subjects

Gut Microbiome of Patients Undergoing Antibiotic Therapy for Orthopedic Device-related Infection

Rifampin and the Contraceptive Implant

Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3)

Susceptibility Testing of Biofilm to Guide Treatment of Periprosthetic Joint Infections

Drug-drug Interaction Study of Gepotidacin

A Drug-drug Interaction Trial to Evaluate the Pharmacokinetics Effect of Rifampicin on Famitinib

Bactiseal Catheter Safety Registry in China

Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct

Surufatinib DDI With a PPI and a CYP3A Inducer

Efficacy of 400 mg Efavirenz Versus Standard 600 mg Dose in HIV/TB Co-infected Patients

Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum

High vs. Standard Dose Rifampicin for Effusive Tuberculous Pericarditis

Phenotyping of High Dose Rifampicin

Pharmacokinetics of Verinurad and Allopurinol in Combination With Cyclosporine and Rifampicin in Healthy Volunteers

Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis

Safety, Tolerability, Pharmacokinetics and Efficacy of SPR720 for the Treatment of Patients With Mycobacterium Avium Complex (MAC) Pulmonary Disease

Fruquintinib CYP3A Inhibitor and Inducer Study

Evaluation of Effect of Rifampin on the Pharmacokinetics of Vonoprazan in Healthy Participants

A Study to Assess the Effect of Food Intake and Drug-drug Interactions of E7090 When Co-administered With Rabeprazole or Rifampin in Healthy Participants

TB-CAPT CORE Truenat Trial

A Rifampin Effect Study of SHR2554 on Healthy Chinese Adult Subjects

IMP4297 DDI (Drug-Drug Interaction)Trial in Healthy Male Volunteers

Drug to Drug Interaction Study of KBP-5074 in Healthy Subjects

Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTB

A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)

Drug-Drug Interaction of SHR1459 With a Strong CYP3A Index Inducer (Rifampicin)

Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide

Treating Tuberculosis With the Lipid Lowering Drug Atorvastatin in Nigeria(ATORvastatin in Pulmonary TUBerculosis)

INSTI's For The Management of HIV-associated TB

Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression

Pharmacokinetics of Twice or Once Daily DTG (50mg) in Children With HIV and TB

A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2

Rifampicin at High Dose for Difficult-to-Treat Tuberculosis

The Effect of Itraconazole and Rifampicin on the Pharmacokinetics of SH-1028

Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation

Study to Evaluate the Effects of Itraconazole and Rifampin on the Pharmacokinetics of ASC40 in Healthy Subjects